Eversept Partners »

Ascendis Pharma AS shares owned by Eversept Partners

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Eversept Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $11M 42k 266.72

More positions owned by Eversept Partners

United Therapeutics Corporation (UTHR)
Abivax Sa Sponsored Ads (ABVX)
Encompass Health Corp (EHC)
Ensign (ENSG)
Vera Therapeutics Cl A (VERA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Brookdale Senior Living (BKD)
Ionis Pharmaceuticals (IONS)
Natera (NTRA)
Travere Therapeutics (TVTX)
Caretrust Reit (CTRE)
Hca Holdings (HCA)
Vaxcyte (PCVX)

View all positions for Eversept Partners

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS